Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasm Recurrence, Local × motexafin gadolinium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Neoplasms 1 Neoplasm Recurrence, Local 1 Neoplasm Metastasis 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

tislelizumab 1 motexafin gadolinium 1 Tamoxifen 1 Talaporfin 1 Radiotherapy 1 Lomustine 1 Irinotecan 1 Folfox protocol 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00054795 2007-05-08

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Pharmacyclics LLC.

Phase 3 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡